Publication:
Successful treatment with anakinra in generalized spiculated porokeratosis and severe hidradenitis suppurativa in a patient with MVK and MEFV mutations

dc.contributor.coauthorOktem, Ayse
dc.contributor.coauthorCavdarli, Busra
dc.contributor.coauthorBostanci, Seher
dc.contributor.coauthorHeper, Aylin
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorRasulova, Günel
dc.contributor.kuauthorVural, Seçil
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-01-19T10:33:58Z
dc.date.issued2023
dc.description.abstractAutoinflammatory diseases of the skin are a complex group of disorders. In recent years, hidradenitis suppurativa (HS) and porokeratosis have been classified as autoinflammatory keratinization diseases.1,2 Porokeratosis is a clinically and genetically heterogeneous keratinization and inflammatory disorder of the skin. Molecular studies have shown an association with mutations in mevalonate pathway genes, such as MVK, PMVK, MVD and FDPS, in patients with porokeratosis.3 We present a late-onset generalized atypical spiculated porokeratosis accompanied by the simultaneous onset of Hurley Stage III HS, another autoinflammatory disease, in a patient with germline heterozygous MVK and MEFV ­mutations.
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessN/A
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.versionN/A
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1093/ced/llac023
dc.identifier.eissn1365-2230
dc.identifier.embargoN/A
dc.identifier.endpage165
dc.identifier.issn0307-6938
dc.identifier.issue2
dc.identifier.pubmed36730507
dc.identifier.scopus2-s2.0-85147319694
dc.identifier.startpage161
dc.identifier.urihttps://doi.org/10.1093/ced/llac023
dc.identifier.urihttps://hdl.handle.net/20.500.14288/26693
dc.identifier.volume48
dc.identifier.wos000953989300031
dc.keywordsAnakinra
dc.keywordsPorokeratosis
dc.keywordsHidradenitis suppurativa
dc.keywordsMVK mutation
dc.keywordsMEFV mutation
dc.keywordsAutoinflammatory keratinization disease
dc.keywordsMevalonate kinase
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofClinical and Experimental Dermatology
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectDermatology
dc.subjectMedical genetics
dc.subjectAutoinflammatory diseases
dc.titleSuccessful treatment with anakinra in generalized spiculated porokeratosis and severe hidradenitis suppurativa in a patient with MVK and MEFV mutations
dc.typeOther
dspace.entity.typePublication
local.contributor.kuauthorVural, Seçil
local.contributor.kuauthorRasulova, Günel
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files